Abstract:Background This study aimed to establish and validate an accurate prognostic model, based on demographic and clinical parameters, for predicting the cancer-specific survival (CSS) of patients with poorly differentiated thyroid carcinoma (PDTC). Materials and methods Patients diagnosed with PDTC between 2004 to 2015 were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Randomly split the data into training and validation sets. Kaplan–Meier analysis with the log-rank test was performed to compare the survival distribution among cases. Univariate and multivariate Cox proportional hazards regression analyses were used to identify independent prognostic factors, which were subsequently utilized to construct a nomogram for predicting the 5- and 10-year cancer-specific survival of patients with PDTC. The discriminative ability and calibration of the nomogram model were assessed using the concordance index and calibration plots, respectively. In addition, we performed a decision curve analysis to assess the clinical value of the nomogram. Simultaneously, we compared the predictive performance of the nomogram model against that of the American Joint Committee on Cancer (AJCC) T-, N-, M-stage. Results A total of 970 eligible patients were randomly assigned to either a training cohort (n = 679) or a validation cohort (n = 291). The Kaplan–Meier analysis revealed that there were no significant differences in cumulative survival based on the race, radiation, and marital status of patients. The stepwise Cox regression model showed that the model was optimal when the following five variables were included: age, tumor size, T-, N-, and M-stage. A nomogram was developed as a graphical representation of the model and exhibited good calibration and discriminative ability in the study. Compared to the T-, N-, and M-stage, the C-index of nomogram (training group: 0.807, validation group: 0.802), the areas under the receiver operating characteristic curve of the training set (5-year AUC: 0.843, 10-year AUC:0.834) and the validation set (5-year AUC:0.878, 10-year AUC:0.811), and the calibration plots of this model all exhibited better performance. At last, compared with T-, N-, and M-stage, the decision curve analysis indicated that the nomogram had excellent clinical net benefit. Conclusions The nomogram developed by us can accurately predict the CSS of PDTC patients. It can help clinicians determine appropriate treatment strategies for poorly differentiated thyroid carcinoma patients.

The prognosis of NX stage differentiated thyroid cancer based on propensity score matching and SEER data.

Clinical Prognostic Factors for Central Neurocytoma and Subgroup Analysis of Different Treatment Measures: A SEER Database-Based Retrospective Analysis from 2003 to 2019

Application and subgroup analysis of competing risks model based on different lymph node staging systems in differentiated thyroid cancer

Chemically Modified Multiwalled Carbon Nanotubes as Efficient Material for Construction of New Al(III) Ion Selective Carbon Paste Electrode

Intracellular melatonin distribution in cultured cell lines

Predictive Factors and Clinicopathological Characteristics of Outcome in Poorly Differentiated Thyroid Carcinoma: a Single-Institution Study.

Prognosis factors analysis of 120 cases differentiated thyroid cancer after follow-up of 8 years

Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score–matched analysis

Prognostic implications of T stage in different pathological types of colorectal cancer: an observational study using SEER population-based data

Different Clinicopathologic Features Predispose to Different Patterns of Distant Metastasis with Heterogeneous Short-Term Prognosis in Patients with Differentiated Thyroid Cancer.

Development and Validation of a Nomogram Model for Cancer-Specific Survival of Patients with Poorly Differentiated Thyroid Carcinoma: A SEER Database Analysis

Differences Between Cancer-Specific Survival of Patients With Anaplastic and Primary Squamous Cell Thyroid Carcinoma and Factors Influencing Prognosis: A SEER Database Analysis

The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988–2008)

Dynamic estimates of survival of patients with poorly differentiated thyroid carcinoma: a population-based study

Incidence and Predictors of Synchronous Bone Metastasis in Newly Diagnosed Differentiated Thyroid Cancer: A Real-World Population-Based Study

Comparisons of prognosis prediction accuracy between modified and unmodified versions of 8th edition ypTNM

Is There a Prognostic Difference among Patients with T3N0-3M0 Non-Small-cell Lung Cancer with Different T3 Descriptors?

Prognostic prediction and treatment options for gastric signet ring cell carcinoma: a SEER database analysis

Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study

The prognostic value of lymph node metastasis and the eighth edition of AJCC for patients with anaplastic thyroid cancer

Metastatic Lymph Node Ratio Can Further Stratify Risk for Mortality in Medullary Thyroid Cancer Patients: A Population-Based Analysis